Skip to content
RxAnte logo — Get more from medicines with patented analytics and value-ba...

RxAnte

Get more from medicines with patented analytics and value-based pharmacy services.

Founded 2011 United States Portland, United States 92 employees Venture round Total: $45.51M Analytics, Health Care +1

General Information

Company Name RxAnte
Founded Year 2011
Location United States Portland, United States
Employees 92
Industries Analytics, Health Care, Pharmaceutical
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with RxAnte. To contact RxAnte, visit rxante.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does RxAnte compare?

A PDF of RxAnte and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting RxAnte soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About RxAnte

RxAnte is a leading predictive analytics and clinical services company founded in 2011. The company's slogan "Get more from medicines with patented analytics and value-based pharmacy services" reflects its core mission. RxAnte is dedicated to improving medication use and health outcomes by providing health plans and providers with actionable insights, strategies, and a portfolio of interventions. With a focus on Analytics, Health Care, and Pharmaceutical industries, RxAnte offers a range of solutions including patented platforms leveraging predictive and decision analytics, advanced program evaluation methods, a web-based workflow solution, and an award-winning call center. Its expertise in advanced analytics, medication adherence, health IT, and quality improvement sets it apart in the market. In December 20, 2022, RxAnte received a $15.00M Venture Round investment from Trinity Capital, highlighting investor confidence in the company's innovative approach and potential for growth. RxAnte's commitment to making medications work better for everyone positions it as a promising investment opportunity in the evolving healthcare landscape.

Business keywords: Predictive analytics, Clinical services, Medication adherence, Health outcomes, Health IT, Quality improvement, Pharmacy services, Medication use, Advanced analytics, Value-based services, Health plans, Providers, Actionable insights, Program evaluation, Decision analytics

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $15.00M 1
Trinity Capital
20 Dec 2022
Debt Financing $10.90M -
21 Oct 2020
Venture Round $5.00M 1
UPMC
01 Apr 2019
Venture Round $10.00M 1
UPMC
30 Sep 2016
Series A $4.61M 2
Aberdare Ventures, West Health Investment Fund
12 Sep 2012

RxAnte Alternatives & Competitors

View All Alternatives
RxAnte vs
Hoap Health
Hoap Health United States

HOAP Health is an AI driven health analytics company that improves health outcomes !!

10 employees
Analytics, Health Care
RxAnte vs
APhA Foundation
APhA Foundation United States

Improving health by inspiring philanthropy, research and innovation that advances pharmacists’ patie...

41 employees
Health Care, Pharmaceutical
RxAnte vs

Enhancing health outcomes through at-home behavioral insights on cancer patients to improve medicati...

Seed
Analytics, Health Care

FAQ About RxAnte

Get more from medicines with patented analytics and value-based pharmacy services.
RxAnte was founded in 2011.
RxAnte is headquartered in Portland, United States.
RxAnte operates in Analytics, Health Care and Pharmaceutical. Its work centres on Predictive analytics, Clinical services, Medication adherence and Health outcomes.
RxAnte has approximately 92 employees.
RxAnte has completed 5 funding rounds, raising a total of $45.51M. The latest funding stage is Venture round.
Top alternatives and competitors to RxAnte include Hoap Health, APhA Foundation, THRIVORS - The Cancer Care Companion, HavenRx, ArborMetrix. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
RxAnte and Hoap Health are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for RxAnte, https://bouncewatch.com/company/rxante, updated 28 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout